Across TCGA pan-cancer cohorts, SOWAHD mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SOWAHD data layer compared with 25 for mass-spec protein and 1 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SOWAHD mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SOWAHD expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.
HNSC and LSCC are the cancer types where SOWAHD mass-spec protein most reproducibly stratifies survival.